Randomized trial shows memory improvement in older adults despite awareness of placebo — Evidence Review

A new study finds that placebo pills—whether participants knew they were fake or not—improved memory, reduced stress, and boosted physical performance in older adults. Most related research supports the potential for both open-label and deceptive placebos to enhance well-being and some aspects of cognitive function.

• Multiple studies show that non-deceptive (open-label) placebos can reduce stress and psychological distress, with some evidence for cognitive benefits; however, effects on objective cognitive performance are more mixed in younger populations than in older adults 7 9 10.
• Prior research on supplements and probiotics for cognitive improvement in older adults often shows limited or inconsistent benefits, suggesting that psychological and contextual factors, such as placebo effects, may play a substantial role in observed improvements 1 2 3 5.
• The current study’s finding that open-label placebos may outperform deceptive placebos in reducing stress aligns with broader evidence that belief in treatment and the therapeutic context are key mediators of placebo effects on both psychological and physiological outcomes 4 8 9 11 13 14.

Study Overview and Key Findings

Understanding how the mind influences aging is a growing area of interest, especially as the global population ages and seeks strategies to maintain cognitive and physical function. This study is noteworthy because it directly compared the effects of open-label (non-deceptive) and deceptive placebos on both cognitive and physical outcomes in healthy older adults—a population typically underrepresented in placebo research. The research also provides new insights into ethical, non-deceptive ways of leveraging placebo effects to potentially support healthy aging.

Property	Value
Organization	Università Cattolica
Journal Name	International Journal of Clinical and Health Psychology
Authors	Diletta Barbiani, Alessandro Antonietti, Francesco Pagnini
Population	Healthy older adults
Sample Size	n=90
Methods	Randomized Controlled Trial (RCT)
Outcome	Cognitive function, physical performance, stress levels
Results	Participants who knew they took a placebo improved stress and memory.

Literature Review: Related Studies

To situate these findings within the broader scientific context, we searched the Consensus database, which contains over 200 million research papers. The following queries were used to identify relevant studies:

1. placebo memory improvement effects
2. stress reduction placebo awareness
3. cognitive outcomes placebo knowledge impact

Below, we summarize key themes from related research and present their main findings:

Topic	Key Findings
Do open-label (non-deceptive) placebos improve cognitive and psychological outcomes?	- Open-label placebos can reduce stress and psychological distress, and may improve subjective well-being; effects on cognitive performance are more apparent in some populations than others 7 9 10. - Cognitive gains from open-label placebos may depend on individual expectations and beliefs 7 10.
How do placebos compare to nutritional and pharmacological interventions for cognition?	- Several supplement interventions (omega-3, probiotics, citicoline) show mixed or limited cognitive benefit in older adults, with some improvements in memory but not always outperforming placebo 1 2 3 5. - Placebo responses may account for some observed benefits in cognitive training and supplementation studies 4.
What mechanisms and contextual factors drive placebo effects?	- Placebo effects are influenced by beliefs, expectations, and the therapeutic context, with neurobiological evidence showing changes in brain activity and stress physiology 11 12 13 14. - Both deceptive and non-deceptive placebos can trigger genuine psychobiological responses, not simply response bias 9 13 14.
Can placebos (deceptive or open-label) enhance physical performance and reduce stress?	- Placebo interventions (even when known to be inert) can reduce stress, anxiety, and emotional distress in both clinical and non-clinical populations 6 8 9 10. - Placebo effects on physical performance in older adults are less studied, but psychological factors such as self-efficacy and expectation play a role 13 14.

Do open-label (non-deceptive) placebos improve cognitive and psychological outcomes?

The new study demonstrates that older adults who knowingly took placebo pills experienced reduced stress and improved memory, with open-label placebos often outperforming deceptive ones in stress reduction. This aligns with prior research showing that open-label placebos can reduce subjective stress and psychological symptoms, though improvements in objective cognitive test performance are less consistently observed in younger or student populations 7 9 10.

• Open-label placebos have been shown to reduce stress and psychological distress in healthy students and non-patient populations, but effects on cognitive test scores are often contingent on positive treatment expectations or pre-existing beliefs 7 10.
• Prior research suggests that the belief in the effectiveness of placebos amplifies their impact, particularly for stress and anxiety reduction 10.
• Non-deceptive placebos have been shown to produce genuine neural and emotional changes, not just self-report bias 9.
• The present study extends these findings to older adults, showing both cognitive and physical benefits.

How do placebos compare to nutritional and pharmacological interventions for cognition?

Several randomized trials of supplements like omega-3 fatty acids, probiotics, and citicoline in older adults have found limited or inconsistent improvements in cognitive function. In some cases, placebo groups improved as much as or more than those receiving active supplements, raising the possibility that expectations or contextual effects drive observed benefits 1 2 3 5. The current study’s demonstration of robust placebo effects underscores the need to consider placebo contributions in intervention research.

• Large-scale trials of omega-3 fatty acids and multidomain interventions failed to show significant cognitive benefits over placebo in older adults with memory complaints 1.
• Probiotic supplementation showed some cognitive improvements in individuals with mild cognitive impairment, but placebo groups also improved, possibly due to study expectations or context 2 3.
• Citicoline supplementation improved memory over placebo in older adults, but the magnitude of placebo effects in such studies remains unclear 5.
• Placebo responses may partly explain gains attributed to cognitive training or supplementation 4.

What mechanisms and contextual factors drive placebo effects?

Placebo effects are increasingly understood as complex psychobiological phenomena shaped by expectations, beliefs, and the therapeutic context. Neurobiological studies reveal that placebo treatments can alter brain activity involved in emotion, reward, and self-appraisal 11 12 13 14. Both deceptive and open-label placebos can induce genuine physiological and psychological responses, as seen in reduced stress markers and neural measures of distress 9 13 14.

• The context and delivery of treatment (including positive suggestions) play a central role in triggering placebo effects 11 13 14.
• Placebos can change brain chemistry and circuitry via cognitive and affective mechanisms, including expectation and learning 12.
• Open-label placebos, when paired with convincing rationale, can produce effects similar to deceptive placebos 9 13.
• The therapeutic encounter, not just the pill, is an essential driver of placebo responses 14.

Can placebos (deceptive or open-label) enhance physical performance and reduce stress?

Open-label and deceptive placebos have been shown to reduce stress, anxiety, and emotional symptoms in various populations, including healthcare workers and non-patient volunteers 6 8 9 10. While most placebo research has focused on psychological outcomes, some evidence indicates that belief and expectation can also influence physical performance, especially in older adults or those with strong self-efficacy beliefs 13 14. The current study is among the first to report objective physical performance gains from both open-label and deceptive placebos in healthy older adults.

• Placebo treatments can reduce short-term stress and anxiety, sometimes rivaling active interventions 6 8 10.
• Open-label placebos may be especially effective in individuals with strong beliefs in their efficacy 10.
• The mind-body connection, including self-perception and mindset, can influence physical and cognitive outcomes 13 14.
• The present study’s 7–9% improvement in physical performance with placebo highlights the potential for harnessing placebo effects in aging populations.

Future Research Questions

While this study advances our understanding of placebo effects in healthy aging, several questions remain. Further research is needed to clarify the mechanisms, durability, and generalizability of open-label placebo effects, as well as to identify which individuals may benefit most and how these approaches compare to other interventions.

Research Question	Relevance
What are the long-term effects of open-label placebo use on cognitive and physical function in older adults?	Most research, including the current and related studies, investigates short-term outcomes; it is unclear if placebo-induced improvements persist or diminish over months or years 1 3 7.
Do individual differences in expectation, beliefs, or personality moderate the effectiveness of open-label placebos?	Several studies suggest that belief in the power of placebos enhances their effects, but which traits or attitudes predict responsiveness is not well understood 7 10 13.
How do open-label placebo effects compare with standard psychological and pharmacological interventions for stress and cognitive decline?	Placebo effects may rival or complement established interventions, but direct head-to-head comparisons are limited, especially in older adults 1 5 6 10.
What are the neurobiological mechanisms underlying open-label placebo effects on cognition and physical function?	While some research has mapped brain activity changes in response to placebos, the mechanisms specific to open-label placebo effects on aging-related outcomes are not fully characterized 11 12 13.
Can open-label placebo interventions be integrated into routine clinical practice for healthy aging?	The current study suggests open-label placebos are both effective and ethical, but practical implementation, acceptability, and scalability in real-world settings need systematic evaluation 14.